search - Mayo Clinic Laboratories
Search Results Test Catalog...
Alzheimer's Disease CSF Biomarkers - Insights
In this month's "Hot Topic," Alicia Algeciras, Ph.D., DABCC, and Joshua Bornhorst, Ph.D., DABCC, discuss Alzheimer's disease CSF biomarkers.
Mayo Clinic Laboratory and Pathology Research Roundup: March 13 - Insights
This week’s Research Roundup highlights the clinical and pathological evolution of giant cell arteritis with a prospective study of follow-up temporal artery biopsies in 40 treated patients.
Mayo Clinic Laboratory and Pathology Research Roundup: March 6 - Insights
This week’s Research Roundup highlights outcomes of warfarin therapy for bioprosthetic valve thrombosis of surgically implanted valves.
Jerry Katzmann, Ph.D., an emeritus consultant in the Mayo Clinic Protein Immunology Laboratory, has received the AACC Academy Award for Outstanding Contributions to Clinical Chemistry in a Selected Area of Research.
Hepatocellular carcinoma - Insights
Hepatocellular carcinoma (HCC) is the third leading cause of death from cancer in the world. While HCC can be effectively treated in its early stages, most patients are not diagnosed until they are symptomatic and at higher grades and...
celiac_disease_diagnostic_testing_algorithm.pdf
08/2024© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Celiac Disease Diagnostic Testing Algorithm Testing for selective IgA deficiency IGA / Immunoglobulin A (IgA), Serum TTGA / Tissue...
February 2021 — Dermatopathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Dermatopathology.
BioPharma Diagnostics - Insights
BioPharma Diagnostics bring Mayo Clinic quality and expertise to collaborative engagements with biopharma, diagnostic and biotech companies to support a range of services, including clinical trial development, assay development, research...
Mayo Clinic Laboratories’ comprehensive dementia testing menu includes evaluations for Alzheimer's disease, autoimmune dementia, and rapidly progressive dementia.